These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
158 related items for PubMed ID: 15332849
1. Inhibition of HIV-1 envelope-mediated fusion by synthetic batzelladine analogues. Bewley CA, Ray S, Cohen F, Collins SK, Overman LE. J Nat Prod; 2004 Aug; 67(8):1319-24. PubMed ID: 15332849 [Abstract] [Full Text] [Related]
2. Design, synthesis and evaluation of potential inhibitors of HIV gp120-CD4 interactions. Boussard C, Klimkait T, Mahmood N, Pritchard M, Gilbert IH. Bioorg Med Chem Lett; 2004 May 17; 14(10):2673-6. PubMed ID: 15109676 [Abstract] [Full Text] [Related]
3. Crambescidin 826 and dehydrocrambine A: new polycyclic guanidine alkaloids from the marine sponge Monanchora sp. that inhibit HIV-1 fusion. Chang L, Whittaker NF, Bewley CA. J Nat Prod; 2003 Nov 17; 66(11):1490-4. PubMed ID: 14640525 [Abstract] [Full Text] [Related]
4. CD4 mimics targeting the mechanism of HIV entry. Yamada Y, Ochiai C, Yoshimura K, Tanaka T, Ohashi N, Narumi T, Nomura W, Harada S, Matsushita S, Tamamura H. Bioorg Med Chem Lett; 2010 Jan 01; 20(1):354-8. PubMed ID: 19926478 [Abstract] [Full Text] [Related]
5. A peptidomimetic HIV-entry inhibitor directed against the CD4 binding site of the viral glycoprotein gp120. Neffe AT, Meyer B. Angew Chem Int Ed Engl; 2004 May 24; 43(22):2937-40. PubMed ID: 15170309 [No Abstract] [Full Text] [Related]
6. Total synthesis of (+)-batzelladine A and (-)-batzelladine D, and identification of their target protein. Shimokawa J, Ishiwata T, Shirai K, Koshino H, Tanatani A, Nakata T, Hashimoto Y, Nagasawa K. Chemistry; 2005 Nov 18; 11(23):6878-88. PubMed ID: 16161173 [Abstract] [Full Text] [Related]
7. Extension of the polyanionic cosalane pharmacophore as a strategy for increasing anti-HIV potency. Cushman M, Insaf S, Paul G, Ruell JA, De Clercq E, Schols D, Pannecouque C, Witvrouw M, Schaeffer CA, Turpin JA, Williamson K, Rice WG. J Med Chem; 1999 May 20; 42(10):1767-77. PubMed ID: 10346929 [Abstract] [Full Text] [Related]
8. Identification of N-phenyl-N'-(2,2,6,6-tetramethyl-piperidin-4-yl)-oxalamides as a new class of HIV-1 entry inhibitors that prevent gp120 binding to CD4. Zhao Q, Ma L, Jiang S, Lu H, Liu S, He Y, Strick N, Neamati N, Debnath AK. Virology; 2005 Sep 01; 339(2):213-25. PubMed ID: 15996703 [Abstract] [Full Text] [Related]
10. Studies towards the total synthesis of batzelladine A. Elliott MC, Long MS. Org Biomol Chem; 2004 Jul 21; 2(14):2003-11. PubMed ID: 15254627 [Abstract] [Full Text] [Related]
11. Enantioselective total synthesis of batzelladine A. Shimokawa J, Shirai K, Tanatani A, Hashimoto Y, Nagasawa K. Angew Chem Int Ed Engl; 2004 Mar 12; 43(12):1559-62. PubMed ID: 15022233 [No Abstract] [Full Text] [Related]
16. CD4 mimics as HIV entry inhibitors: lead optimization studies of the aromatic substituents. Narumi T, Arai H, Yoshimura K, Harada S, Hirota Y, Ohashi N, Hashimoto C, Nomura W, Matsushita S, Tamamura H. Bioorg Med Chem; 2013 May 01; 21(9):2518-26. PubMed ID: 23535561 [Abstract] [Full Text] [Related]
17. Docking and 3D-QSAR studies of BMS-806 analogs as HIV-1 gp120 entry inhibitors. Teixeira C, Serradji N, Maurel F, Barbault F. Eur J Med Chem; 2009 Sep 01; 44(9):3524-32. PubMed ID: 19410340 [Abstract] [Full Text] [Related]
18. Anti-HIV activity of semisynthetic derivatives of andrographolide and computational study of HIV-1 gp120 protein binding. Uttekar MM, Das T, Pawar RS, Bhandari B, Menon V, Nutan, Gupta SK, Bhat SV. Eur J Med Chem; 2012 Oct 01; 56():368-74. PubMed ID: 22858223 [Abstract] [Full Text] [Related]